Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Recent results from the Daily Antiretroviral Therapy (DART 1) trial show promising results for antiretroviral-naïve patients.

Study of efavirenz over 96 weeks shows durability, efficacious regimen